Teligent Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
18,224.00
33,740.00
44,250.00
66,881.00
67,251.00
65,865
Cost of Goods Sold (COGS) incl. D&A
12,139.00
16,948.00
22,935.00
32,194.00
39,879.00
43,480
Gross Income
6,085.00
16,792.00
21,315.00
34,687.00
27,372.00
22,385
SG&A Expense
6,167.00
12,886.00
22,251.00
32,145.00
39,169.00
35,560
EBIT
82.00
3,906.00
-
2,542.00
11,797.00
13,175
Unusual Expense
-
2,300.00
20,888.00
-
-
7,474
Non Operating Income/Expense
-
-
450.00
422.00
7,719.00
3,371
Interest Expense
199.00
782.00
12,799.00
13,818.00
11,198.00
12,298
Pretax Income
281.00
5,424.00
6,703.00
11,698.00
15,276.00
36,318
Income Tax
197.00
173.00
35.00
287.00
85.00
62
Consolidated Net Income
84.00
5,251.00
6,668.00
11,985.00
15,191.00
36,256
Net Income
84.00
5,251.00
6,668.00
11,985.00
15,191.00
36,256
Net Income After Extraordinaries
84.00
5,251.00
6,668.00
11,985.00
15,191.00
36,256
Net Income Available to Common
1,392.00
5,251.00
6,668.00
11,985.00
15,191.00
36,256
EPS (Basic)
0.03
0.09
0.07
0.23
0.28
0.68
Basic Shares Outstanding
43,517.60
49,817.70
52,872.80
53,078.20
53,324.00
53,592.90
EPS (Diluted)
0.03
0.09
0.07
0.23
0.28
0.68
Diluted Shares Outstanding
43,517.60
64,207.20
67,112.00
53,078.20
53,324.00
53,592.90
EBITDA
453.00
4,541.00
238.00
6,321.00
7,156.00
7,500
Preferred Dividends
1,308.00
-
-
-
-
-

About Teligent

View Profile
Address
105 Lincoln Avenue
Buena New Jersey 08310
United States
Employees -
Website http://www.teligent.com
Updated 07/08/2019
Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. It also provides contract manufacturing services to the pharmaceutical, over-the-counter, and cosmetic markets. The company was founded by Jane E.